The aim of the present study was to assess the additional costs and health outcomes of biocompatible over conventional solutions in incident peritoneal dialysis patients to guide practice decisions.
Most recently, Bastiaannet et al. [34] performed a cost-effectiveness study assessing the additional costs of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
The costing component assessed the additional costs to the health sector due to the introduction of curative interventions at community level by HSAs for the treatment of malaria, diarrhoea and pneumonia in children under 5.
The costing component assessed the additional costs to the health sector due to the introduction of curative interventions at community level by HEWs for the treatment of malaria, diarrhoea and pneumonia in children under 5.
The costing component assessed the additional costs to the health sector including due to the introduction of curative interventions at community level by CBAs for the treatment of malaria, diarrhoea and pneumonia in children under 5.
The costing component assessed the additional costs to the health sector including due to the introduction of curative interventions at community level by APEs for the treatment of malaria, diarrhoea and pneumonia in children under 5.
The costing component assessed the additional costs to the health sector due to the introduction of curative interventions at community level by Agents de Sante Communautaires (ASCs) for the treatment of malaria, diarrhoea and pneumonia in children under 5, assuming delivery according to protocols.
The costing component, for the purpose of this evaluation, assessed the additional costs incurred by the health services (including donor funding) due to the introduction of the curative interventions by CHWs for the treatment of malaria, diarrhoea and pneumonia in children under 5, if this was done according to country protocols.
Most of the costs are in transport, logistics, and time: assessing additional species would have added very little to costs.
Because TMZ is associated with high acquisition costs, it is important to assess whether these additional costs are associated with measurable benefits.
